Skip to main content
SpringerLink
Log in

Active Surveillance: The Canadian Experience

  • Chapter
  • First Online:
Active Surveillance for Localized Prostate Cancer

Part of the book series: Current Clinical Urology ((CCU))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cooperberg MR, et al. Time trends in treatment of localized prostate cancer. J Clin Oncol. 2010;28:1117–23.

    Article  PubMed  Google Scholar 

  2. Matzkin H, Patel JP, Altwein JE. Soloway MS stage T1A carcinoma of prostate. Urology. 1994;43(1): 11–21.

    Article  PubMed  CAS  Google Scholar 

  3. Choo R, Klotz L, Danjoux C, Morton GC, DeBoer G, Szumacher E, Fleshner N, Bunting P, Hruby G. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol. 2002;167(4):1664–9.

    Article  PubMed  Google Scholar 

  4. Klotz L. Active surveillance for prostate cancer: for whom? J Clin Oncol. 2005;23(32):8165–9.

    Article  PubMed  Google Scholar 

  5. Zhang L, Loblaw A, Klotz L. Modeling prostate specific antigen kinetics in patients on active surveillance. J Urol. 2006;176(4 Pt 1):1392–7.

    Article  PubMed  Google Scholar 

  6. Krakowsky Y, Loblaw A, Klotz L. Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristics. J Urol. 2010;184(1):131–5.

    Article  PubMed  Google Scholar 

  7. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28(1):126–31.

    Article  PubMed  Google Scholar 

  8. Remzi M, Fong YK, Dobrovits M, Anagnostou T, Seitz C, Waldert M, Harik M, Marihart S, Marberger M, Djavan B. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol. 2005;174(4 Pt 1):1256–60.

    Article  PubMed  Google Scholar 

  9. van As NJ, Norman AR, Thomas K, Khoo VS, Thompson A, Huddart RA, Horwich A, Dearnaley DP, Parker CC. Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol. 2008;54(6): 1297–305.

    Article  PubMed  Google Scholar 

  10. Carter HB, Kettermann A, Warlick C, Metter EJ, Landis P, Walsh PC, Epstein JI. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol. 2007;178(6):2359–64.

    Article  PubMed  Google Scholar 

  11. Soloway MS, Soloway CT, Williams S, Ayyathurai R, Kava B, Manoharan M. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int. 2008;101(2):165–9.

    PubMed  Google Scholar 

  12. Roemeling S, Roobol MJ, de Vries SH, Wolters T, Gosselaar C, van Leenders GJ, Schröder FH. Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome. Eur Urol. 2007;51(5):1244–50.

    Article  PubMed  Google Scholar 

  13. Khatami A, Aus G, Damber JE, Lilja H, Lodding P, Hugosson J. PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden section. Int J Cancer. 2007;120(1):170–4.

    Article  PubMed  Google Scholar 

  14. van den Bergh RC, Vasarainen H, van der Poel HG, Vis-Maters JJ, Rietbergen JB, Pickles T, Cornel EB, Valdagni R, Jaspars JJ, van der Hoeven J, Staerman F, Oomens EH, Rannikko A, Roemeling S, Steyerberg EW, Roobol MJ, Schröder FH, Bangma CH. Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study. BJU Int. 2010;105(7):956–62.

    Article  PubMed  Google Scholar 

  15. Johansson J-E. Expectant management of early stage prostatic cancer: Swedish experience. J Urol. 1994;152:1753.

    PubMed  CAS  Google Scholar 

  16. Johansson JE, Andrén O, Andersson S, Dickman PW, Holmberg L, Magnuson A, Adami HO. Natural history of early, localized prostate cancer. JAMA. 2004;291:2713–9.

    Article  PubMed  CAS  Google Scholar 

  17. Klotz L, Thompson I. Mortality in ‘low risk’ disease—Scandinavian trial vs Sunnybrook active surveillance. N Engl J Med. 2011;365(6):589.

    Google Scholar 

  18. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A, O’Leary M, Walker-Corkery E, Yao SL. Outcomes of localized prostate cancer following conservative management. JAMA. 2009;302(11):1202–9.

    Article  PubMed  CAS  Google Scholar 

  19. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005;294(4):433–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

    Laurence Klotz M.D., F.R.C.S.C.

Authors
  1. Laurence Klotz M.D., F.R.C.S.C.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laurence Klotz M.D., F.R.C.S.C. .

Editor information

Editors and Affiliations

  1. University of Toronto, Sunnybrook Health Sciences Centre, Division of Urology, Toronto, M4N 3M5, Ontario, Canada

    Laurence Klotz

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Klotz, L. (2012). Active Surveillance: The Canadian Experience. In: Klotz, L. (eds) Active Surveillance for Localized Prostate Cancer. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-912-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-912-9_8

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-911-2

  • Online ISBN: 978-1-61779-912-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation